T. Matsuoka

Erythropoietin is highly elevated in vitreous fluid of patients with proliferative diabetic retinopathy.

H. Nishigori, M. Osako, M. Kure, 2005, Diabetes care.

A study of urinary myo-inositol as a sensitive marker of glucose intolerance.

S. Kawazu, Mamoru Takahashi, H. Shiomi, 2004, Clinica chimica acta; international journal of clinical chemistry.

Effect of acarbose on postprandial lipid metabolism in type 2 diabetes mellitus.

M. Noritake, S. Kado, T. Murakami, 1998, Diabetes research and clinical practice.

A trial to assess the amount of insulin antibodies in diabetic patients by surface plasmon resonance.

H. Nishigori, M. Kure, Masahiko Kure, 2005, Internal medicine.

Hepatocyte Growth Factor in Vitreous Fluid of Patients With Proliferative Diabetic Retinopathy and Other Retinal Disorders

H. Nishigori, T. Okano, S. Kado, 1998, Diabetes Care.

ProMMP-9 (92 kDa gelatinase) in vitreous fluid of patients with proliferative diabetic retinopathy.

H. Nishigori, T. Okano, M. Noritake, 1999, Life sciences.

The insulin ball

K. Iwaya, K. Nemoto, K. Kou, 2009, The Lancet.

Type 1 diabetes mellitus caused by treatment with interferon-beta.

M. Kure, S. Kado, Y. Katsura, 2000, Internal medicine.

Assessment of diabetic autonomic neuropathy using twenty-four-hour spectral analysis of heart rate variability: a comparison with the findings of the Ewing battery.

F. Ohsuzu, B. Takase, A. Kurita, 2002, Japanese heart journal.